Savara Announces New U.S. Health Claims Data Analysis Finds Over 50% Increase in the Estimated Number of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) Patients Compared to Previous Claims ...
Access to claims data enables plan sponsors to identify cost drivers, assess the impact of formulary decisions and negotiate ...
Hospitals conducted more than 200,000 unnecessary spinal fusion/laminectomy or vertebroplasty procedures on Medicare beneficiaries 65 and older from 2020 to 2022. This generated about $1.9 billion in ...
A holistic approach to identity is essential to protect the nation’s health assistance programs from criminal networks and ...
Insurance companies operating in Texas closed almost half the claims filed by homeowners last year without paying anything, part of a rising trend that is shifting more costs onto property owners, ...
Upwards of $2.1 billion has been requested by nearly 2,000 people who claim that they were abused as children while in state ...
-- Approximately 5,500 Autoimmune PAP Patients in the U.S. Identified in the Updated Analysis that Leveraged a More Recent and Comprehensive Claims Data Source -- -- New England Journal of Medicine ...
Savara Inc. (the “Company”) (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced an increased estimate of autoimmune PAP diagnosed ...